0001209191-17-003674.txt : 20170113 0001209191-17-003674.hdr.sgml : 20170113 20170113163316 ACCESSION NUMBER: 0001209191-17-003674 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170111 FILED AS OF DATE: 20170113 DATE AS OF CHANGE: 20170113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADURO BIOTECH, INC. CENTRAL INDEX KEY: 0001435049 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 510-848-4400 MAIL ADDRESS: STREET 1: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 FORMER COMPANY: FORMER CONFORMED NAME: ADURO BIOTECH DATE OF NAME CHANGE: 20080514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Templeman Blaine CENTRAL INDEX KEY: 0001653641 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37345 FILM NUMBER: 17528216 MAIL ADDRESS: STREET 1: C/O ADURO BIOTECH, INC. STREET 2: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-11 0 0001435049 ADURO BIOTECH, INC. ADRO 0001653641 Templeman Blaine C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710 0 1 0 0 Executive VP, General Counsel Common Stock 2017-01-11 4 S 0 3785 11.95 D 37300 D The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. Includes 1,621 shares and 584 shares acquired by the Reporting Person under the Issuer stock purchase plan on May 13, 2016 and November 15, 2016, respectively. /s/ Jennifer Lew, Attorney-in-Fact 2017-01-13